Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model

Teng K.-Y.Han J.Zhang X.SHU-HAO HSUHe S.Wani N.A.Barajas J.M.Snyder L.A.Frankel W.L.Caligiuri M.A.Jacob S.T.Yu J.Ghoshal K.2020-03-022020-03-0220171535-7163https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011655226&doi=10.1158%2f1535-7163.MCT-16-0124&partnerID=40&md5=4aaa019e0f7637be05d38347a9b04a6ahttps://scholars.lib.ntu.edu.tw/handle/123456789/467348[SDGs]SDG3Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse modeljournal article10.1158/1535-7163.MCT-16-0124279801022-s2.0-85011655226